论文部分内容阅读
肢端肥大症是一种颇为难治的内分泌疾病,病因至今未明。本文从胃肠道内分泌学着眼,对肢端肥大症的病因和治疗进行了新的大胆的设想,并采用胃(胰)蛋白酶对15例患者进行了临床验证,取得了较为满意的近期疗效。作者通过临床观察,认为肢端肥大症不仅是垂体前叶生长激素分泌过多所致,还与胃肠激素功能紊乱,造成胃肠内分泌病变有关。用胃(胰)蛋白酶治疗本病,似对胃肠激素有良好的调节作用,特别是促进D细胞的分泌,使血浆生长抑索水平提高。故使用后能取得一定的临床效果,从当前国内外治
Acromegaly is a rather refractory endocrine disease, the etiology has not yet been identified. In this paper, from the perspective of gastrointestinal endocrinology, the etiology and treatment of acromegaly new bold idea, and the use of gastric (pancreatic) protease clinical validation of 15 patients, and achieved satisfactory results in the near future. The author through clinical observation, that acromegaly is not only caused by excessive secretion of growth hormone in the anterior pituitary, but also with gastrointestinal hormone disorders, resulting in gastrointestinal endocrine lesions. The stomach (pancreatic) protease treatment of the disease, it seems to have good regulation of gastrointestinal hormones, in particular, to promote the secretion of D cells, so that the level of plasma growth inhibition increased. Therefore, after use can achieve a certain clinical effect, from the current domestic and foreign governance